Peak bone mass has been shown to be a significant predictor of risk for osteoporosis.
Previous studies have demonstrated that skeletal mass accumulation is under strong genetic …

Originally classified as a variant of silent corticotroph adenoma, silent subtype 3 adenomas
are a distinct histologic variant of pituitary adenoma of unknown cytogenesis. We reviewed …

Hawker GA, Ridout R, Harris VA, Chase CC, Fielding LJ, Biggar WD. Alendronate in the
treatment of low bone mass in steroid-treated boys with Duchenne’s muscular dystrophy. …

Objective: To clarify the selection of medical therapy following transsphenoidal surgery in
patients with acromegaly, based on growth hormone (GH)/insulin-like growth factor 1 (IGF-1) …

Objective Pituitary apoplexy is associated with visual, cranial nerve, and endocrine dysfunction.
In this article, the results of surgical and conservative management of pituitary apoplexy …

We examined the effect of a fracture clinic intervention in reducing previously documented
undertreatment of osteoporosis (OP) in individuals with fragility fractures. Fragility fracture …

One way to decrease the risk of osteoporosis is to maximize peak bone mass. Peak bone
mass may be moderately influenced by lifestyle behaviors: increasing calcium and exercise, …

Background: In Canada, more than 2 million people live with osteoporosis, a disease that
increases the risk for fractures, which result in excess mortality and morbidity, decreased …

Tumors of hypothalamic neurons that produce vasopressin are rare. We retrieved all cases
of vasopressin-positive tumors in the sellar region from the database of the Department of …

Background: Cognitive dietary restraint (CDR) may mediate subclinical ovulatory disturbances,
which may result in loss of bone mineral density (BMD). CDR is associated with greater …